Table 5. Clinical and Laboratory... | American Society of Hematology

Table 5.

Clinical and Laboratory Findings in ET Patients and Results of Clonality Analysis Using the AR Gene

No.	Age at Diagnosis	Follow-up Time	Treatment	C.S	Unfractionated Blood	T-Lymphocyte	Granulocyte Fraction	Platelet Counts at Diagnosis ×10⁹/L
						Fraction
1^5-150	36	53	Hydrea	+	MO	MO	MO	1,100
2^5-150	34	148	Hydrea	+	MO	MO	MO	889
32	57	7	Hydrea	−	MO	MO	MO	1,300
33^5-150	68	56	Hydrea	−	MO	MO	MO	962
34	70	48	0	+	MO	PO	MO	693
35^5-150	46	12	Hydrea	+	MO	PO	MO	1,060
36	16	70	Hydrea	−	MO	PO	MO	907
37^5-150	43	19	0	+	MO	PO	MO	1,500
38^5-150	68	1	0	−	MO	PO	MO	843
39	42	2	0	+	MO	PO	MO	990
40^5-150	63	36	Hydrea	−	MO	PO	MO	1,025
41^5-150	47	42	Hydrea	+	MO	PO	MO	1,067
42^5-150	61	84	Hydrea	−	MO	PO	MO	631
43	37	1	0	−	PO	PO	PO	880
44	16	2	0	−	PO	PO	PO	900
45	13	14	Interferon	−	PO	PO	PO	1,400
46^5-150	65	94	Hydrea	−	PO	PO	PO	624

No.	Age at Diagnosis	Follow-up Time	Treatment	C.S	Unfractionated Blood	T-Lymphocyte	Granulocyte Fraction	Platelet Counts at Diagnosis ×10⁹/L
						Fraction
1^5-150	36	53	Hydrea	+	MO	MO	MO	1,100
2^5-150	34	148	Hydrea	+	MO	MO	MO	889
32	57	7	Hydrea	−	MO	MO	MO	1,300
33^5-150	68	56	Hydrea	−	MO	MO	MO	962
34	70	48	0	+	MO	PO	MO	693
35^5-150	46	12	Hydrea	+	MO	PO	MO	1,060
36	16	70	Hydrea	−	MO	PO	MO	907
37^5-150	43	19	0	+	MO	PO	MO	1,500
38^5-150	68	1	0	−	MO	PO	MO	843
39	42	2	0	+	MO	PO	MO	990
40^5-150	63	36	Hydrea	−	MO	PO	MO	1,025
41^5-150	47	42	Hydrea	+	MO	PO	MO	1,067
42^5-150	61	84	Hydrea	−	MO	PO	MO	631
43	37	1	0	−	PO	PO	PO	880
44	16	2	0	−	PO	PO	PO	900
45	13	14	Interferon	−	PO	PO	PO	1,400
46^5-150	65	94	Hydrea	−	PO	PO	PO	624

Follow-up (months) at the time of clonality analysis.

Abbreviations: C.S, ischemic or hemorrhagic symptoms; MO, monoclonal; PO, polyclonal; AR, androgen receptor gene.

Patients reported in our previous study.14